Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse.
Inhalable solvents possess significant abuse liability and produce many of the neurobehavioral effects typically associated with central nervous system-depressant agents, including motor incoordination, anxiolysis, and the elicitation of signs of physical dependence on withdrawal. We tested the hypothesis that the commonly abused solvents toluene, 1,1,1-trichloroethane (TCE), and trichloroethylene (TCY) affect ligand-gated ion channel activity, as do other classes of central nervous system-depressive agents. TCE and toluene, like ethanol, reversibly enhanced gamma-aminobutyric acid (GABA)(A) receptor-mediated synaptic currents in rat hippocampal slices. All three inhalants significantly and reversibly enhanced neurotransmitter-activated currents at alpha1beta1 GABA(A) and alpha1 glycine receptors expressed in Xenopus oocytes. We previously identified specific amino acids of glycine and GABA(A) receptor subunits mediating alcohol and volatile anesthetic enhancement of receptor function. Toluene, TCE, and TCY were tested on several glycine receptor mutants, some of which were insensitive to ethanol and/or enflurane. Toluene and TCY enhancement of glycine receptor function was seen in all these mutants. However, the potentiating effects of TCE were abolished in three mutants and enhanced in two, a pattern more akin to that seen with enflurane than ethanol. These data suggest that inhaled drugs of abuse affect ligand-gated ion channels, and that the molecular sites of action of these compounds may overlap with those of ethanol and the volatile anesthetics.
Beckstead
M J
MJ
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Weiner
J L
JL
Eger
E I
EI
Gong
D H
DH
Mihic
S J
SJ
D000280:Administration, Inhalation; D018685:Anesthetics, Inhalation / Q000009:adverse effects; D000818:Animals; D004594:Electrophysiology; D000431:Ethanol / Q000009:adverse effects; D013287:Illicit Drugs / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009865:Oocytes; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000502:physiology; D018009:Receptors, Glycine / Q000187:drug effects* / Q000502:physiology; D014982:Xenopus laevis
D018685:Anesthetics, Inhalation; D013287:Illicit Drugs; D011963:Receptors, GABA-A; D018009:Receptors, Glycine; D000431:Ethanol